Relevant bibliographies by topics / Systemic lupus erythematosus

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Systemic lupus erythematosus'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Systemic lupus erythematosus.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Systemic lupus erythematosus"

1

Chinnusamy, Manokaran, Ram Arvind Viswanathan, Sathiyanarayanan Janakiraman, and Roshna Elayidath. "Drug-Induced Lupus Erythematosus Associated with Proton Pump Inhibitor." Journal of Health and Allied Sciences NU 10, no. 03 (September 8, 2020): 132–34. http://dx.doi.org/10.1055/s-0040-1716601.

Full text
Abstract:
AbstractDrug-induced lupus erythematosus is an autoimmune phenomenon where the drug exposure leads to the development of systemic lupus erythematous like clinical features. Drug-induced lupus erythematosus can be divided into systemic lupus erythematous, subacute cutaneous lupus erythematous, and chronic cutaneous lupus erythematous. Here, we report a case of a 29-year-old female presented with systemic lupus erythematous due to chronic use of proton pump inhibitors, which is considered to be very rare.
APA, Harvard, Vancouver, ISO, and other styles
2

Garbelini-Lima, Cleide, Gabriela Evangelista de Almeida, Sidharta Quércia Gabdelha, Andrea Cavalcante de Souza, Mara Lúcia Gomes de Souza, and Virginia Vilasboas Figueiras. "Discoid Lupus Erythematosus of the Scalp in a Patient with Systemic Lupus Erythematosus: A Case Report with Complete Hair Regrowth." Journal of the Portuguese Society of Dermatology and Venereology 79, no. 2 (June 26, 2021): 155–58. http://dx.doi.org/10.29021/spdv.79.2.1283.

Full text
Abstract:
Scalp involvement with hair loss is common in systemic lupus erythematosus. Discoid lupus erythematosus may cause scarring alopecia, characterized by well-delimited erythematous plaques with scales, follicular hyperkeratosis and atrophy, which is considered a trichological emergency. Early diagnosis and treatment are necessary in order to prevent permanent hair loss. We describe a 44 years’ old female patient with systemic lupus erythematosus for 4 years, with multiple areas of occipitoparietal alopecia, erythematous plaques, atrophy, scales and some bloody crusts. Trichoscopy, histopathology and direct immunofluorescence led to the diagnosis of discoid lupus erythematosus. After 9 months treatment with thalidomide there was complete hair regrowth.
APA, Harvard, Vancouver, ISO, and other styles
3

N, Habib. "Review Article: Systemic Lupus Erythematosus." Open Access Journal of Microbiology & Biotechnology 5, no. 1 (2020): 1–4. http://dx.doi.org/10.23880/oajmb-16000158.

Full text
Abstract:
Systemic lupus erythematosus or SLE is a persistent heterogeneous autoimmune disease that affects multisystem of the body. It is distinguished by acute and chronic inflammation of various tissues and even organs of the body principally the skin and joints. Systemic lupus erythematosus is a multisystem disorder and hence, it can affect any tissues, organs and even systems of the body. There are few categories of lupus for instance, lupus dermatitis or cutaneous lupus erythematosus (CLE) that affects the skin and causes malar rash, discoid lupus erythematosus (DLE) as well as systemic lupus erythematosus that causes damage to single or multiple internal organs. The damage is due to the inflammation that is caused by direct antibody reaction to the body tissues as well the deposition of immune complexes. Glucocorticoids, immunosuppressant, and anti- malarial are the combination therapy used to treat SLE besides providing counseling and awareness. Lupus erythematosus in any form particularly systemic lupus erythematosus (SLE) are prevalent in women compared to men with ratio of 6:1. It has the tendency to affect all ages but most frequently attacks women of aged 20 to 45 years old compared to men. On the other hand, if lupus erythematosus causes damage to internal organs either single or multiple, it is known as systemic lupus erythematosus. The damage is due to the inflammation that is caused by direct antibody reaction to the body tissues as well the deposition of immune complexes.
APA, Harvard, Vancouver, ISO, and other styles
4

Franjic, Sinisa. "Systemic Lupus Erythematosus in Gynecology." International Journal of Reproductive Research 1, no. 1 (December 22, 2022): 01–03. http://dx.doi.org/10.58489/2836-2225/005.

Full text
Abstract:
Systemic lupus erythematosus is a chronic autoimmune disease that can affect various organs and parts of the body, especially the skin, joints, blood, kidneys, and central nervous system. Systemic lupus erythematosus is not a contagious disease, it is an autoimmune disease in which the immune system loses the ability to distinguish foreign from the patient's own tissues and cells. The immune system makes mistakes and produces, among other things, autoantibodies that recognize their own cells as foreign and attack them. The result is an autoimmune reaction that causes inflammation. Inflammation means that the affected part of the body becomes warm, red, swollen and sometimes painfully sensitive. If the signs of inflammation are long-lasting, as they may be in the case of systemic lupus erythematosus, tissue damage and its normal function may occur. Therefore, the goal of treatment of systemic lupus erythematosus is to alleviate inflammation. A number of hereditary risk factors along with various environmental factors are thought to be responsible for this impaired immune response. Systemic lupus erythematosus is known to be caused by a variety of factors, including hormonal imbalances during puberty, stress, and environmental factors such as sun exposure, viral infections, and medications.
APA, Harvard, Vancouver, ISO, and other styles
5

Chottawornsak, N., P. Rodsaward, S. Suwannachote, M. Rachayon, T. Rattananupong, T. Deekajorndech, P. Asawanonda, D. Chiewchengchol, and P. Rerknimitr. "Skin signs in juvenile- and adult-onset systemic lupus erythematosus: clues to different systemic involvement." Lupus 27, no. 13 (October 18, 2018): 2069–75. http://dx.doi.org/10.1177/0961203318805851.

Full text
Abstract:
Objective We aim to explore the differences of skin signs between juvenile- and adult-onset systemic lupus erythematosus and to identify their associations to the development of systemic involvement. Methods A retrospective chart review of 377 systemic lupus erythematosus patients was performed. Results In total, 171 patients with juvenile systemic lupus erythematosus and 206 with adult systemic lupus erythematosus were studied. All patients were of Southeast Asian descent. The mean duration of follow up was 8.18 ± 6.19 and 9.36 ± 7.68 years for juvenile systemic lupus erythematosus and adult systemic lupus erythematosus, respectively. At diagnosis, most patients presented with acute cutaneous lupus erythematosus, whereas chronic cutaneous lupus erythematosus was twice as common in adult systemic lupus erythematosus ( p < 0.001). The mean Systemic Lupus Erythematosus Disease Activity Index of juvenile systemic lupus erythematosus was significantly higher than that of adult systemic lupus erythematosus (14.29 ± 7.13 vs 11.27 ± 6.53). Multivariate analysis revealed the following associations in juvenile systemic lupus erythematosus: acute cutaneous lupus erythematosus and non-scarring alopecia with increased risk of arthralgia, mucosal ulcers with leukopenia, cutaneous vasculitis with seizure, and finding of granular casts. On the contrary, the associations for adult systemic lupus erythematosus were oral ulcers with arthralgia and cutaneous vasculitis with myositis. Conclusions Cutaneous signs in systemic lupus erythematosus may signal prognostic implication. Interestingly, despite similar cutaneous lesions in systemic lupus erythematosus, different ages of onset are associated with different systemic involvement.
APA, Harvard, Vancouver, ISO, and other styles
6

Powers, David B. "Systemic Lupus Erythematosus and Discoid Lupus Erythematosus." Oral and Maxillofacial Surgery Clinics of North America 20, no. 4 (November 2008): 651–62. http://dx.doi.org/10.1016/j.coms.2008.07.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Feingold-Link, Mara. "Systemic Lupus Erythematosus." Annals of Internal Medicine 168, no. 6 (March 20, 2018): 452. http://dx.doi.org/10.7326/m17-2553.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kiriakidou, Marianthi. "Systemic Lupus Erythematosus." Annals of Internal Medicine 159, no. 7 (October 1, 2013): ITC4. http://dx.doi.org/10.7326/0003-4819-159-7-201310010-01004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Greenberg, Brent, and Margaret Michalska. "Systemic lupus erythematosus." Postgraduate Medicine 106, no. 6 (January 1999): 213–23. http://dx.doi.org/10.3810/pgm.1999.11.779.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dall'Era, Maria, and John C. Davis. "Systemic lupus erythematosus." Postgraduate Medicine 114, no. 5 (November 2003): 31–40. http://dx.doi.org/10.3810/pgm.2003.11.1528.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Systemic lupus erythematosus"

1

Teh, Lee-Suan. "Neuropsychiatric systemic lupus erythematosus." Thesis, University of Aberdeen, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.240703.

Full text
Abstract:
Neuropsychiatric (NP) symptoms are relatively common in patients with SLE. The diverse and dramatic clinical presentations, the unclear pathogenesis, the lack of diagnostic test/s and uncertainties about the optimal management are some problems facing a clinician. When serum anti P antibodies were claimed to be highly correlated to lupus psychosis, this needed confirmation. An ELISA for measuring anti P antibodies was developed and validated. The prevalence of anti P antibodies was determined in different patient groups in a large retrospective study. Although anti P antibodies were highly specific for SLE, there was no correlation between the presence of these antibodies and lupus psychosis or other NP symptoms. Two prospective studies were carried out to eliminate any bias in our retrospective study. In one, none of the patients developed psychosis and these antibodies were not found to be specific for lupus depression or anxiety. In the other, anti P antibodies were measured in Malaysian Chinese SLE patients. No correlation was found between these antibodies and NP-SLE but a high prevalence of these antibodies was demonstrated in this group. Genetic studies showed that there was an increase in HLA-Dr2w16X subtype allele in anti P-positive patients but this did not reach significance. The usefulness of measuring antineuronal antibodies in helping to diagnose NP-SLE was examined but these antibodies were not better indicators of NP-SLE. Although the clinical correlations of anti P antibodies remain controversial, anti P antibodies were found to selectively bind to neuroblastoma cell surfaces in vitro but the nature of the surface antigen was not determined. Finally, sera from patients with lupus psychosis were found to significantly influence the response of neuroblastoma cells to agonist-induced stimulation and if confirmed, would offer an explanation for the reversible changes in cell function associated with psychiatric lupus.
APA, Harvard, Vancouver, ISO, and other styles
2

Bernatsky, Sasha. "Malignancy in systemic lupus erythematosus." Thesis, McGill University, 2001. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=32761.

Full text
Abstract:
Objectives. (1) To estimate cancer incidence in systemic lupus erythematosus (SLE) as compared to the general population. (2) To estimate the sensitivity and specificity of methods of cancer ascertainment. (3) To determine the prevalence of malignancy risk factors in SLE. Methods. (1) We determined the incidence of malignancy in the Montreal General Hospital (MGH) lupus cohort, through linkage with the Quebec tumor registry. Standardized incidence ratios (SIRS) were generated, using Quebec population rates. In addition, a meta-analysis was performed by pooling data from eight cohort studies of malignancy in SLE. (2) We administered a postal survey to cohort members to determine risk factors for cancer and self-report of cancer occurrence. For dead or lost-to-follow-up patients, data was abstracted from charts. We calculated the sensitivity and specificity of self-report and chart review for cancer ascertainment, compared to registry linkage results. (3) Using the data collected on self-report and chart review, we compared risk factor prevalence within the MGH cohort to that of the Quebec population. Results. (1) Observed cancers in our cohort were greater than what would be expected; for all cancers, the SIR was 1.8 (95% Confidence Interval 1.2--2.6). The meta-analysis SIR (for all malignancies) was 1.67 (1.42--1.94). Postal survey and chart review methods demonstrated high specificity. Sensitivity was imperfect, but did not greatly effect estimation of the SIR estimate. (2) Our lupus cohort had a distinct profile of risk factors for malignancy compared to the general population; differences included more prevalent nulliparity, obesity, and use of hormone replacement therapy. Conclusions. The risk of malignancy in SLE patients is increased. Risk factor profiles could influence the incidence of certain malignancies in SLE.
APA, Harvard, Vancouver, ISO, and other styles
3

Clarke, Alexander James. "Autophagy in Systemic Lupus Erythematosus." Thesis, King's College London (University of London), 2015. http://kclpure.kcl.ac.uk/portal/en/theses/autophagy-in-systemic-lupus-erythematosus(1e5a4a5e-99f7-456e-bcb4-634a4e3fd986).html.

Full text
Abstract:
Autophagy has emerged as a critical homeostatic mechanism in lymphocytes, influencing proliferation and differentiation. I sought to explore the role of autophagy in the pathogenesis of human and murine lupus, a disease in which B cells are critical effectors of pathology. Autophagy was assessed using multiple techniques in NZB/W and control mice, and in patients with SLE compared to healthy controls. I evaluated the phenotype of the B cell compartment in Vav-Atg7-/- mice in vivo, and examined human and murine plasmablast formation following inhibition of autophagy. I found activation of autophagy in early developmental stages of B cell development in a lupus mouse model even before disease-onset, and which progressively increased with age. In human disease, again autophagy was activated compared with healthy controls, principally in naïve B cells. B cells isolated from Vav-Atg7-/- mice failed to effectively differentiate into plasma cells following stimulation in vitro. Similarly, human B cells stimulated in the presence of autophagy inhibition did not differentiate into plasmablasts. My data suggest activation of autophagy is a mechanism for survival of autoreactive B cells, and also demonstrate that it is required for plasmablast differentiation, processes that induce significant cellular stress. The implication of autophagy in two major pathogenic pathways in SLE suggests the potential to use inhibition of autophagy as a novel treatment target.
APA, Harvard, Vancouver, ISO, and other styles
4

Brown, Aaron Clifford. "Molecular and Phenotypic Characterization of the Y-Linked Autoimmune Accelerator (YAA)." Fogler Library, University of Maine, 2007. http://www.library.umaine.edu/theses/theses.asp?highlight=1&Cmd=abstract&ID=BMB2007-011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wong, Kee-lam, and 黃基林. "Systemic lupus erythematosus in Hong Kong." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1990. http://hub.hku.hk/bib/B31981410.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Peschken, Christine A. "Systemic lupus erythematosus in Manitoba Aboriginals." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape9/PQDD_0019/MQ55086.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Svenungsson, Elisabet. "Cardiovascular disease in systemic lupus erythematosus /." Stockholm, 2003. http://diss.kib.ki.se/2003/91-7349-501-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Russell, Andrew Ian. "Genetic predisposition to systemic lupus erythematosus." Thesis, Imperial College London, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.406513.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Li, Hei Philip, and 李曦. "Subphenotype stratification in systemic lupus erythematosus." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48334765.

Full text
Abstract:
Subsets of systemic lupus erythematosus (SLE) patients with distinct patterns of disease manifestations and autoantibody production have been reported, but seldom have these two phenomena been analysed together. Cluster analysis was performed on 1928 Chinese SLE patients based on autoantibody profile and the frequencies of various clinical manifestations were compared between each cluster. Separate association analyses between individual autoantibodies and clinical manifestations, as well as between clinical manifestations, were also performed. This study identifies three separate autoantibody clusters each with different clinical manifestations, and proposes that the phenomena of autoantibody clustering and clinical subsets may be inter-related. Patient clusters could also be stratified into a bipolar spectrum. On one end are patients with over-representation of anti-dsDNA and renal disorder; whilst on the other end are two distinct autoantibody clusters (anti-Sm/anti-RNP/aPL and aPL/anti-Ro/anti-La) with overlapping of other non-renal manifestations. Patient stratification could aid disease prediction and subsequent management. These findings may also elucidate disease pathogenesis and guide future study on potential common pathological processes within autoantibody clusters.
published_or_final_version
Paediatrics and Adolescent Medicine
Master
Master of Research in Medicine
APA, Harvard, Vancouver, ISO, and other styles
10

Courtney, Philip. "Leukocyte apoptosis in systemic lupus erythematosus." Thesis, Queen's University Belfast, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.326415.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Systemic lupus erythematosus"

1

Eggleton, Paul, and Frank J. Ward, eds. Systemic Lupus Erythematosus. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0326-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Miescher, Peter A., ed. Systemic Lupus Erythematosus. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-79622-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Smolen, Josef S., and Christoph C. Zielinski. Systemic Lupus Erythematosus. Berlin, Heidelberg: Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71642-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

1945-, Lahita Robert G., ed. Systemic lupus erythematosus. 2nd ed. New York: Churchill Livingstone, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

A, Miescher Peter, ed. Systemic lupus erythematosus. Berlin: Springer-Verlag, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

1945-, Lahita Robert G., ed. Systemic lupus erythematosus. 3rd ed. San Diego: Academic Press, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

1945-, Lahita Robert G., ed. Systemic lupus erythematosus. 4th ed. Amsterdam: Elsevier Academic Press, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

A, Miescher Peter, ed. Systemic lupus erythematosus. Berlin: Springer-Verlag, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

A, Miescher Peter, ed. Systemic lupus erythematosus. Berlin: Springer-Verlag, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

D, Gladman D., and Hochberg Marc C, eds. Systemic lupus erythematosus. London: Baillière Tindall, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Systemic lupus erythematosus"

1

Theisler, Charles. "Lupus (Systemic Lupus Erythematosus)." In Adjuvant Medical Care, 206–8. New York: CRC Press, 2022. http://dx.doi.org/10.1201/b22898-212.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bermas, Bonnie L. "Systemic Lupus Erythematosus and Pregnancy." In Lupus Erythematosus, 183–96. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-1189-5_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kalman, R. S., and J. L. Wolf. "Gastrointestinal Manifestations of Systemic Lupus Erythematosus." In Lupus Erythematosus, 153–68. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-1189-5_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gayed, Mary, Chee-Seng Yee, Sasha Bernatsky, and Caroline Gordon. "Co-morbidities in Systemic Lupus Erythematosus." In Lupus Erythematosus, 229–49. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-1189-5_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Goldberg, Hilary J., and Paul F. Dellaripa. "Pulmonary Manifestations of Systemic Lupus Erythematosus." In Lupus Erythematosus, 115–25. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-1189-5_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lattanzi, Bianca, and Angelo Ravelli. "Systemic Lupus Erythematosus." In Textbook of Clinical Pediatrics, 1629–39. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-02202-9_159.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ying, Howard S., and Catherine Q. Zhu. "Systemic Lupus Erythematosus." In Uveitis, 9–13. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-52974-1_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bridges, Alan J. "Systemic Lupus Erythematosus." In Pain, 1215–18. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-99124-5_259.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Niaudet, Patrick, and Rémi Salomon. "Systemic Lupus Erythematosus." In Pediatric Nephrology, 1127–53. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-76341-3_47.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bertolaccini, Maria Laura, Graham R. V. Hughes, and Munther A. Khamashta. "Systemic Lupus Erythematosus." In Diagnostic Criteria in Autoimmune Diseases, 3–8. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-60327-285-8_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Systemic lupus erythematosus"

1

BEZERRA BRASILEIRO, ROMANO, PRISCILA GARCIA CÂMARA CABRAL TAVARES, FRANCISCO HELIALDO SOUSA DE OLIVEIRA FILHO, and PRISCILA DOURADO EVANGELISTA. "DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS." In SBR 2021 Congresso Brasileiro de Reumatologia. Sociedade Brasileira de Reumatologia, 2021. http://dx.doi.org/10.47660/cbr.2021.1795.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

DUARTE, ANNA BEATRIZ GOMES SOUZA, ELISA GUIMARÃES MOTTA, ADIB CHICRE MANSUR, GUILHERME SALLES DE ESCOBAR GONÇAVES, LARISSA BARROS DE OLIVEIRA, and GABRIELLEN VITIELLO. "FEVER IN SYSTEMIC LUPUS ERYTHEMATOSUS." In 36º Congresso Brasileiro de Reumatologia. São Paulo: Editora Blucher, 2019. http://dx.doi.org/10.5151/sbr2019-102.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Durand, P. H., E. Stratulat, D. Jansen, and I. D. Weir. "Systemic Lupus Erythematosus Presenting as Acute Lupus Pneumonitis." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5318.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Egeli, Bugra, Asli Ece Soykut, and Serdal Ugurlu. "226 Comorbidity in systemic lupus erythematosus." In 13th International Congress on Systemic Lupus Erythematosus (LUPUS 2019), San Francisco, California, USA, April 5–8, 2019, Abstract Presentations. Lupus Foundation of America, 2019. http://dx.doi.org/10.1136/lupus-2019-lsm.226.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

FERRAÇO DALMASO, BARBARA, Ketty Lysie Libardi Lira Machado, Laura Gonçalves Aguiar, Heitor Filipe Surlo, Laís Pizzol Pasti, Paula dos Santos Athayde, Mariana de Oliveira Macabú, et al. "MULTIBACILAR LEPROSY MIMICKING SYSTEMIC LUPUS ERYTHEMATOSUS." In SBR 2021 Congresso Brasileiro de Reumatologia. Sociedade Brasileira de Reumatologia, 2021. http://dx.doi.org/10.47660/cbr.2021.2102.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Barboza, Flavio, Tassia Caroline Beckert Viana, Eduarda Judith Dias Jacome Silva, Raquel Gerep Pereira, Bruna Luiza Oliveira Lima, Thalyne Aparecida Leite de Lima, Maitê Luise Zanette, et al. "Systemic Lupus Erythematosus mimicking Hodgkin's lymphoma." In Congresso Brasileiro de Reumatologia 2020. Sociedade Brasileira de Reumatologia, 2021. http://dx.doi.org/10.47660/cbr.2020.16937.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Souza da Paz, Adriane, Gustavo Luiz Behrens Pinto, and Mittermayer Barreto Santiago. "COLLAPSING GLOMERULOPATHY IN SYSTEMIC LUPUS ERYTHEMATOSUS." In Congresso Brasileiro de Reumatologia 2020. Sociedade Brasileira de Reumatologia, 2021. http://dx.doi.org/10.47660/cbr.2020.17616.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

dos Santos Cavalcante, Anauá Fernanda, Sabrina Longo, Lucas P. G., Julia Goginski, Aline Neppel, Macleise A. Kemes, Thiago Alberto G. dos Santos, and Thelma L. Skare. "DRY EYE IN SYSTEMIC LUPUS ERYTHEMATOSUS." In Congresso Brasileiro de Reumatologia 2020. Sociedade Brasileira de Reumatologia, 2021. http://dx.doi.org/10.47660/cbr.2020.17297.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Voulgari, PV, P. Katsimbri, Y. Alamanos, and AA Drosos. "FRI0115 Systemic lupus erythematosus in men." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.150.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Moszkorzova, L., C. Dostal, J. Marek, Z. Lacinova, and L. Musilova. "FRI0137 Prolactin in systemic lupus erythematosus." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.172.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Systemic lupus erythematosus"

1

Yang, Jianguo, Fuyu Zhao, Xinpeng Zhou, Yuying sun, Xueping Lun, Jiaojiao Cao, and Bing Fan. Survival and prognosis analysis of systemic lupus erythematosus-pulmonary hypertension: a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2023. http://dx.doi.org/10.37766/inplasy2023.4.0017.

Full text
Abstract:
Review question / Objective: The study aimed to evaluate survival rates and prognosis in systemic lupus erythematosus (SLE) patients with pulmonary hypertension (PH) using meta-analysis. (P: patients with SLE-PH; I: No intervention; C: No comparator; O: survival and prognosis; S: meta-analysis). Condition being studied: Pulmonary hypertension (PH) is a life-threatening condition characterized by elevated pulmonary arteries pressure due to increased pulmonary vascular resistance1. Symptoms of PH are nonspecific but typically include exertional dyspnea and fatigue. Systemic lupus erythematosus (SLE) is characterized by aberrant immune activity leading to variable clinical manifestations ranging from mild fatigue and joint pain to severe and life-threatening organ damage. Recent data from lupus registries have provided more accurate estimates of SLE incidence and prevalence, which showed Lupus is more common in non-white populations.
APA, Harvard, Vancouver, ISO, and other styles
2

Tseng, Ping-Tao. Audiovestibular Dysfunction in Systemic Lupus Erythematosus Patients: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2024. http://dx.doi.org/10.37766/inplasy2024.6.0046.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Harley, John. Genome-Wide Association Study in African-Americans with Systemic Lupus Erythematosus. Fort Belvoir, VA: Defense Technical Information Center, September 2012. http://dx.doi.org/10.21236/ada574794.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Harley, John. Genome-Wide Association Study in African-Americans with Systemic Lupus Erythematosus. Fort Belvoir, VA: Defense Technical Information Center, September 2013. http://dx.doi.org/10.21236/ada592038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Harley, John. Genome-Wide Association Study in African-Americans With Systemic Lupus Erythematosus. Fort Belvoir, VA: Defense Technical Information Center, September 2011. http://dx.doi.org/10.21236/ada554417.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Xie, Juan, Dan Zhao, Lei Pan, Wenfang Xu, Beibei Wang, and Yan Yang. Experiences of Patients Living with Systemic Lupus Erythematosus: A Qualitative Meta-synthesis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2022. http://dx.doi.org/10.37766/inplasy2022.1.0033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gontar, I. P., O. A. Rusanova, O. I. Emelyanova, S. S. Khortieva, and E. G. Cherkesova. AUTOIMMUNITY ISSUES IN PATIENTS WITH SYSTEMIC SCLERODERMA AND SYSTEMIC LUPUS ERYTHEMATOSUS WITH PREDOMINANT PULMONARY INVOLVEMENT. "PLANET", 2019. http://dx.doi.org/10.18411/978-5-907192-54-6-2019-xxxvi-73-81.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

liu, zhihui, ruijuan cheng, and yi liu. Evaluation of anifrolumab safety in systemic lupus erythematosus: A meta-analysis and systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0054.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pfeifer, Maria. Self-help Support Groups: Choices in Participation Among Women Facing Systemic Lupus Erythematosus (SLE). Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.6685.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lun, Xueping, Jianguo Yang, Ying Liu, Fuyu Zhao, Zhiliang Wei, Yuying Sun, and Xinpeng Zhou. Risk factors of systemic lupus erythematosus patients with pulmonary hypertension: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2023. http://dx.doi.org/10.37766/inplasy2023.8.0079.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Systemic lupus erythematosus' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography